Form 4 for PROK PROKIDNEY CORP.
Accepted 2024-04-16 00:00:00 ET · period of report 2024-04-01 · accession 0000950170-24-044836 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2024-04-16 | 2024-04-01+ | PROK | Weber Darin J. | SVP of Regulatory Development | S - Sale | $1.73 | -84.4K | 189.7K | -31% | -$146.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Shares | 2024-04-01 | S | D | 300 | $1.69 | 273,773 | D | — | — | (F1) The reported sale of shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2023. |
| 2 | Common | Class A Ordinary Shares | 2024-04-12 | S | D | 84,103 | $1.73 | 189,670 | D | — | — | (F2) The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.69 to $1.77, inclusive. The reporting person undertakes to provide to ProKidney Corp., any security holder of ProKidney Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. (F1) The reported sale of shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2023. |